Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxol in Advanced Salivary Gland Malignancies
NCT00002632Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 1995
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in salivary gland cancer (SGC), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Objective Response Rate. Started May 1995; status: completed.
02
Drugs
paclitaxel
03
Conditions
salivary gland cancer (SGC)
Beyond the preview
Go deeper on NCT00002632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002632.